• Comparison of graft loss rate in patients receiving ivig drug with patients receiving ivig and leflunomide regimen.
Not Applicable
- Conditions
- patients with BK virus infection in kidney transplant patients.Kidney transplant infectioT86.13
- Registration Number
- IRCT20230214057417N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
They were transplanted for the first time, and the age of the patients is over 18 years old, and the CKD patients were not in the field of autoimmune diseases.
Exclusion Criteria
Autoimmune diseases - Any drug side effects - Having a history of treatment due to BK VIRUS
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method